Nachrichten zur Seattle Genetics Inc. Aktie

US-Konzern Merck & Co übernimmt Krebsforscher Velosbio

KENILWORTH/SAN DIEGO (dpa-AFX) - Der Pharmakonzern Merck & Co baut sein Krebsgeschäft mit einem weiteren…

Seattle Genetics (SGEN) Q3 2020 Earnings Call Transcript

SGEN earnings call for the period ending September 30, 2020....…

Seattle Genetics (SGEN) Q3 Earnings and Revenues Top Estimates

Seattle Genetics (SGEN) delivered earnings and revenue surprises of 4475.00% and 166.81%, respectively, for the quarter ended September 2020. Do…

XFRA : INSTRUMENT_EVENT EQUBF_01

CAPITAL ADJUSTMENT INFORMATION - 13.10.2020;Das Instrument US8125781026 SEATTLE GENETICS DL-,001 EQUITY wird ex Kapitalmassnahme gehandelt am 13.10.2020 The instrument…

XFRA : XFRA: Deletion of Instruments from XETRA - 12.10.2020

The following instruments on XETRA do have their last trading day on 12.10.2020 Die folgenden Instrumente in XETRA haben ihren letzten…

XFRA : ISIN Change

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen US8125781026 Seagen Inc. 12.10.2020 US81181C1045 Seagen Inc. 13.10.2020 Tausch 1:1 CA95914Q3052 Oro X Mining Corp. 12.10.2020 CA68702W1077 Oro X...…

XFRA : SGT: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

XFRA : INSTRUMENT_SUSPENSION EQUBF_01

Instrument ID [10739] (SGT - US8125781026) suspended...…

SEATTLE GENETICS INC /WA: 8-K Report

8-K...…

Seattle Genetics changes name to Seagen

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Seattle Genetics Stock Jumped 24% in September

Investors celebrated news of a big partnership -- and a big capital infusion....…

Final Trades: Seattle Genetics, Greenbrier, CVS Health & more

The "Halftime Report" traders give their top picks to watch for the second half....…

Agenus Vs. Seattle Genetics Cervical Cancer Clinical Trial Results

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Seattle Genetics/Genmab antibody-drug conjugate shows positive effect in cervical cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020

Media Release COPENHAGEN, Denmark and BOTHELL, Wash., 21 September 2020...…

SEATTLE GENETICS INC /WA: 8-K Report

8-K...…

Astellas and Seattle Genetics Announce PADCEV® (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer

TOKYO and BOTHELL, Wash. , Sept. 18, 2020 /PRNewswire/ -- …

Seattle Genetics Up on Two New Oncology Deals With Merck

Seattle Genetics (SGEN) strikes a couple of deals with Merck to co-develop ladiratuzumab vedotin for breast cancer and other solid…

Merck Buys Rights to Co-Develop Seattle Genetics ADC Drug

Merck (MRK) buys rights to co-develop/co-commercialize Seattle Genetics ladiratuzumab vedotin. It acquires exclusive license to commercialize Tukysa for HER2-positive cancers…

Thinking about trading options or stock in Novavax, Camping World, Coca-Cola, Seattle Genetics, or Scientific Games?

NEW YORK , Sept. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVAX,…

Merck to purchase $1bn equity stake in Seattle Genetics

Merck and Seattle Genetics have entered into two strategic oncology collaborations to commercialise Seattle Genetics antibody-drug conjugate (ADC) ladiratuzumab vedotin…

Merck Inks Multibillion-Dollar Deal With Seattle Genetics, Including Equity

Merck is acquiring $1 billion in Seattle Genetics shares as part of a wide-ranging collaboration agreement....…

Final Trades: Seattle Genetics, Booking Holdings, Boston Scientific & more

The "Halftime Report" traders give their top picks to watch for the second half....…

Seattle Genetics: Megadeal mit Merck & Co!

Zu den größten Gewinnern am US-Aktienmarkt zählt heute die Aktie des Biotechunternehmens Seattle Genetics (WKN: 602322). Grund hierfür ist ein…

Merck’s Partnership With Seattle Genetics Is a Bet on a New Anticancer Strategy

Merck launched a $4.2 billion partnership with Seattle Genetics on Monday, for development of antibody-drug conjugates, a treatment that zeroes…

Merck to invest US$1bn in Seattle Genetics as part of oncology collaboration agreement

Merck (NYSE:MRK) is to acquire US$1bn equity stake in Seattle Genetics, Inc. (Nasdaq:SGEN) as part of a new strategic oncology…

Pharmabranche: US-Konzern Merck & Co steigt bei Seattle Genetics ein

Mit einer Milliarde Euro beteiligt sich der US-Pharmakonzern bei Seattle Genetics. Ziel ist die Weiterentwicklung von zwei Krebsmedikamenten....…

Merck to Invest $1 Billion in Seattle Genetics

The companies will collaborate on developing and selling Seattle Genetics breast-cancer treatments. Merck said it is buying five million shares…

US-Konzern Merck & Co steigt für Krebsmittelforschung bei Seattle Genetics ein

KENILWORTH/BOTHELL (dpa-AFX) - Der US-Pharmakonzern Merck & Co (Merck) und das amerikanische Biotechnologieunternehmen Seattle Genetics machen bei der Weiterentwicklung …

Mega-Deal: Merck & Co steigt bei AKTIONÄR-Tipp Seattle Genetics ein – Aktie hebt ab

Es geht Schlag auf Schlag im Biotech-Sektor. Nach dem Bekanntwerden der milliardenschweren Übernahmeofferte von Gilead für den Krebs-Spezialisten Immunomedics sorgt…

Shares of Seattle Genetics jump as Merck makes up to $4.2 billion investment

Shares of Seattle Genetics rallied 9.3% in premarket trading on Monday after it announced two cancer deals with Merck…

US-Konzern Merck & Co steigt für Krebsmittelforschung bei Seattle Genetics ein

KENILWORTH/BOTHELL (dpa-AFX) - Der US-Pharmakonzern Merck & Co und das amerikanische Biotechnologieunternehmen Seattle Genetics …

Seattle Genetics teams up with Merck for oncology candidates

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Merck to buy $1 bln stake in Seattle Genetics, co-develop cancer therapy

Drugmaker Merck & Co Inc would buy $1 billion worth of equity stake in Seattle Geneticss common stock, the companies…

Merck & Co beteiligt sich für 1 Milliarde Dollar an Seattle Genetics

Von Dave Sebastian NEW YORK (Dow Jones)--Der US-Pharmakonzern Merck Co arbeitet mit Seattle Genetics bei Brustkrebsmedikamenten zusammen. Wie…

Merck to buy $1 billion equity stake in Seattle Genetics

Merck & Co Inc said on Monday it would buy $1 billion worth of equity stake in Seattle Geneticss…

SEATTLE GENETICS INC /WA: 8-K Report

8-K...…

Seattle Genetics (SGEN) Down 10.2% Since Last Earnings Report: Can It Rebound?

Seattle Genetics (SGEN) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Seattle Genetics (SGEN) to Receive Milestone Fee from Glaxo

Seattle Genetics (SGEN) to win a milestone fee from GlaxoSmithKline following the EU approval of Blenrep, developed by the latter.…

Time to buy sinking Seattle Genetics? #AskHalftime

The "Halftime Report" traders answer viewer questions in #AskHalftime....…

SEATTLE GENETICS INC /WA: 8-K Report

8-K...…

Seattle Genetics (SGEN) Q2 2020 Earnings Call Transcript

SGEN earnings call for the period ending June 30, 2020....…

Seattle Genetics (SGEN) Q2 Earnings Beat, Adcetris Aids Sales

Seattle Genetics (SGEN) reports a narrower-than-expected loss and beats sales estimates in the second quarter of 2020....…

SEATTLE GENETICS INC /WA: 10-Q Report

10-Q...…

SEATTLE GENETICS INC /WA: 8-K Report

8-K...…

Seattle Genetics (SGEN) Reports Q2 Loss, Tops Revenue Estimates

Seattle Genetics (SGEN) delivered earnings and revenue surprises of 6.90% and 8.28%, respectively, for the quarter ended June 2020. Do…

Seattle Genetics EPS beats by $0.48, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Seattle Genetics: Profitable Products, Exciting Pipeline

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Piper Sandler Downgrades Seattle Genetics, Says Visibility Limited On Value Creation

Seattle Genetics, Incs (NASDAQ: SGEN) stock already reflects the urothelial bladder cancer opportunity, according to Piper Sandler. Latest Ratings…

Why Seattle Genetics Shares Climbed 48.7% in the First Half

Two drug approvals in just a few months gave investors reason to cheer....…